Interim Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current Assets
Cash and cash equivalents	$ 15,002	$ 7,926
Restricted cash-funds held in trust	390,138	467,798
Trade receivables	173,791	121,276
Government remittances receivable	31,745	38,578
Other receivables	13,808	20,624
Inventory	4,071	5,389
Prepaid expenses and deposits	30,609	46,028
Total Current Assets	659,164	707,619
Intangible Assets	219,237	237,271
Long-lived Assets, net	4,574,406	4,762,453
Long-Term Assets	4,793,643	4,999,724
Total Assets	5,452,807	5,707,343
Current Liabilities
Accounts payable	951,664	958,313
Government remittances payable	68,695	35,187
Accrued liabilities	648,165	487,592
Advance		3,255
Deferred revenue	16,214	9,239
Current portion of long-term debt	3,533,565	3,859,401
Current portion of obligations under capital lease	440,364	218,069
Convertible promissory notes	1,485,673	1,406,029
Mortgage payable	1,811,669	1,934,276
Loans payable to related party	70,490
Total Liabilities	9,026,499	8,911,361
Stockholders' Deficiency
Preferred stock, $.0001 par value, 10,000,000 authorized, none issued and outstanding
Common stock, $.0001 par value, 150,000,000 authorized, 60,501,830 (2019- 51,784,504) shares issued and outstanding	6,052	5,180
Additional paid-in capital	8,525,946	7,450,091
Subscription payable	7,250
Stock compensation reserve		1,000,000
Accumulated deficit	(12,204,787)	(11,449,497)
Accumulated other comprehensive income (loss)	91,847	(209,792)
Stockholders' deficiency	(3,573,692)	(3,204,018)
Total Liabilities and Stockholders' Deficiency	$ 5,452,807	$ 5,707,343